Literature DB >> 29402822

Metabolic Syndrome Is Associated with Health-Related Quality of Life in Suspected Patients with Nonalcoholic Steatohepatitis.

Ali Gholami1,2,3, Farhad Zamani4, Bayan Hosseini5, Rahim Sharafkhani6, Mansooreh Maadi4, Zahra Moosavi Jahromi7,8, Maryam Khazaee-Pool9, Masoudreza Sohrabi4.   

Abstract

OBJECTIVE: This study was designed to examine the effect of metabolic syndrome (MetS) on health-related quality of life (HRQOL) in patients with suspected nonalcoholic steatohepatitis (NASH). SUBJECTS AND METHODS: Three hundred thirty-two patients (236 males and 96 females) with suspected NASH from the Amol cohort study were included in this study. MetS was diagnosed based on Adult Treatment Panel III criteria and HRQOL was measured using the 12-Item Short-Form Health Survey (SF-12) questionnaire (with 8 subscales and 2 summary components). A multivariable linear regression model was used to assess the independent effect of MetS on HRQOL.
RESULTS: The mean age of the study population was 42 ± 13 years (range 18-82). The prevalence of MetS was 43.4% (n = 144) and the mean scores on the Physical Component Summary (PCS) and the Mental Component Summary were 72.4 ± 20.86 and 42.7 ± 12.42, respectively. The multivariable linear regression model showed that MetS was negatively associated with 4 subscales of HRQOL that included: role limitations due to physical problems (RP) (B = -14.05, p = 0.004), bodily pain (BP) (B = -7.37, p = 0.02), vitality (VT) (B = -7.72, p = 0.022), and role limitations due to emotional problems (RE) (B = -12.67, p = 0.005) after adjustment for other variables. Also, MetS had a borderline association with the general health and mental health subscales and the PCS (p < 0.1).
CONCLUSION: In this study, there was a strong association between MetS and 4 subscales (RP, BP, VT, and RE) of HRQOL in patients with suspected NASH; this could be considered as a part of health policy to improve general health.
© 2018 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  Metabolic syndrome; Nonalcoholic steatohepatitis; Quality of life; Twelve-Item Short-Form Health Survey

Mesh:

Year:  2018        PMID: 29402822      PMCID: PMC5968304          DOI: 10.1159/000487397

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  29 in total

1.  Health-related quality of life in patients with non-alcoholic fatty liver disease.

Authors:  A A Dan; J B Kallman; A Wheeler; Z Younoszai; R Collantes; S Bondini; L Gerber; Z M Younossi
Journal:  Aliment Pharmacol Ther       Date:  2007-09-15       Impact factor: 8.171

Review 2.  Should visceral fat be reduced to increase longevity?

Authors:  Carmine Finelli; Luigi Sommella; Saverio Gioia; Nicolina La Sala; Giovanni Tarantino
Journal:  Ageing Res Rev       Date:  2013-06-11       Impact factor: 10.895

Review 3.  What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome?

Authors:  Giovanni Tarantino; Carmine Finelli
Journal:  World J Gastroenterol       Date:  2013-06-14       Impact factor: 5.742

4.  Epidemiology and Natural History of Non-alcoholic Fatty Liver Disease.

Authors:  Alita Mishra; Zobair M Younossi
Journal:  J Clin Exp Hepatol       Date:  2012-07-21

Review 5.  Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.

Authors:  Erin K Spengler; Rohit Loomba
Journal:  Mayo Clin Proc       Date:  2015-07-26       Impact factor: 7.616

6.  The effect of metabolic syndrome components on exercise performance in patients with intermittent claudication.

Authors:  Andrew W Gardner; Polly S Montgomery
Journal:  J Vasc Surg       Date:  2008-04-14       Impact factor: 4.268

7.  Metabolic syndrome and health-related quality of life in Iranian population.

Authors:  Nizal Sarrafzadegan; Mojgan Gharipour; Mohammad Arash Ramezani; Katayoun Rabiei; Behzad Zolfaghar; Ali Akbar Tavassoli; Maryam Boshtam; Sonia Zarfeshani; Alireza Khosravi; Alireza Yousefi
Journal:  J Res Med Sci       Date:  2011-03       Impact factor: 1.852

8.  Assessment of health utilities and quality of life in patients with non-alcoholic fatty liver disease.

Authors:  Mehmet Sayiner; Maria Stepanova; Huong Pham; Bashir Noor; Mercedes Walters; Zobair M Younossi
Journal:  BMJ Open Gastroenterol       Date:  2016-08-16

9.  Clinical Manifestations and Diagnosis of Nonalcoholic Fatty Liver Disease.

Authors:  Mahmoodreza Khoonsari; Mohammadreza Mohammad Hosseini Azar; Ramak Ghavam; Khadijeh Hatami; Mosa Asobar; Ali Gholami; Abdolhalim Rajabi; Fahimeh Safarnezhad Tameshkel; Bahare Amirkalali; Masoudreza Sohrabi
Journal:  Iran J Pathol       Date:  2017-04-01

Review 10.  Nonalcoholic fatty liver disease: Diagnostic biomarkers.

Authors:  Fatemeh Hadizadeh; Elham Faghihimani; Peyman Adibi
Journal:  World J Gastrointest Pathophysiol       Date:  2017-05-15
View more
  3 in total

1.  Validation of a Quantification Method for Curcumin Derivatives and Their Hepatoprotective Effects on Nonalcoholic Fatty Liver Disease.

Authors:  Young-Seob Lee; Seon Min Oh; Qian-Qian Li; Kwan-Woo Kim; Dahye Yoon; Min-Ho Lee; Dong-Yeul Kwon; Ok-Hwa Kang; Dae Young Lee
Journal:  Curr Issues Mol Biol       Date:  2022-01-15       Impact factor: 2.976

2.  Prediction of the development of metabolic syndrome by the Markov model based on a longitudinal study in Dalian City.

Authors:  Xiao Tang; Qigui Liu
Journal:  BMC Public Health       Date:  2018-06-07       Impact factor: 3.295

3.  The burden of non-alcoholic steatohepatitis: A systematic review of health-related quality of life and patient-reported outcomes.

Authors:  Zobair Younossi; Priya Aggarwal; Ichhya Shrestha; João Fernandes; Pierre Johansen; Margarida Augusto; Sunita Nair
Journal:  JHEP Rep       Date:  2022-06-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.